Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Nan Liu

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Journal of Natural Products|February 6, 2009
Cytotoxic phenanthrenequinones and 9,10-dihydrophenanthrenes from Calanthe arisanensisChia-Lin Lee, Fang-Rong Chang, Ming-Hon Yen, et al.
Cancer Medicine|May 22, 2023
MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasisTzu-Hsiu Tsai, Chien-Hung Gow, Yi-Nan Liu, et al.
Oncotarget|February 11, 2016
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsShang-Gin Wu, Yi-Nan Liu, Meng-Feng Tsai, et al.
Oncotarget|April 15, 2015
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancerYi-Nan Liu, Tzu-Hua Chang, Meng-Feng Tsai, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 17, 2024
Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestrationNing Ji, Hui Li, Yixuan Zhang, et al.
Toxicology|April 29, 2023
Long-term exposure to arsenic in drinking water leads to myocardial damage by oxidative stress and reduction in NOYi-Xin Cui, Lu Dong, Meng Zhang, et al.
Molecular Cancer Therapeutics|April 20, 2026
Mechanisms of Acquired Resistance Following Dual EGFR/MET Inhibition in MET-Amplified EGFR TKI-Resistant Lung CancerYen-Ting Lin, Yi-Nan Liu, Ya-Chieh Hsu, et al.
Frontiers in Oncology|March 9, 2026
The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancerTzu-Hua Chang, Meng-Feng Tsai, Shang-Gin Wu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 18, 2012
[Diagnostic accuracy research of needle puncture biopsy during operation for pulmonary single nodules]Jin-feng Chen, Yi-nan Liu, Nan Wu, et al.
Neoplasia (New York, N.Y.)|July 18, 2018
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung CancerChien-Hung Gow, Yi-Nan Liu, Huei-Ying Li, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Journal of Natural Products|February 6, 2009
Cytotoxic phenanthrenequinones and 9,10-dihydrophenanthrenes from Calanthe arisanensisChia-Lin Lee, Fang-Rong Chang, Ming-Hon Yen, et al.
Cancer Medicine|May 22, 2023
MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasisTzu-Hsiu Tsai, Chien-Hung Gow, Yi-Nan Liu, et al.
Oncotarget|February 11, 2016
The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsShang-Gin Wu, Yi-Nan Liu, Meng-Feng Tsai, et al.
Oncotarget|April 15, 2015
IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancerYi-Nan Liu, Tzu-Hua Chang, Meng-Feng Tsai, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 17, 2024
Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestrationNing Ji, Hui Li, Yixuan Zhang, et al.
Toxicology|April 29, 2023
Long-term exposure to arsenic in drinking water leads to myocardial damage by oxidative stress and reduction in NOYi-Xin Cui, Lu Dong, Meng Zhang, et al.
Molecular Cancer Therapeutics|April 20, 2026
Mechanisms of Acquired Resistance Following Dual EGFR/MET Inhibition in MET-Amplified EGFR TKI-Resistant Lung CancerYen-Ting Lin, Yi-Nan Liu, Ya-Chieh Hsu, et al.
Frontiers in Oncology|March 9, 2026
The STAT3-ZEB1 axis contributes to CCL2-mediated resistance to osimertinib in lung cancerTzu-Hua Chang, Meng-Feng Tsai, Shang-Gin Wu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 18, 2012
[Diagnostic accuracy research of needle puncture biopsy during operation for pulmonary single nodules]Jin-feng Chen, Yi-nan Liu, Nan Wu, et al.
Neoplasia (New York, N.Y.)|July 18, 2018
Oncogenic Function of a KIF5B-MET Fusion Variant in Non-Small Cell Lung CancerChien-Hung Gow, Yi-Nan Liu, Huei-Ying Li, et al.
Pageof 10